Your browser doesn't support javascript.
loading
Efficacy of Dupilumab for Controlling Severe Atopic Dermatitis in a Patient with Hyper-IgE Syndrome.
Lévy, Romain; Béziat, Vivien; Barbieux, Claire; Puel, Anne; Bourrat, Emmanuelle; Casanova, Jean-Laurent; Hovnanian, Alain.
Afiliación
  • Lévy R; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR 1163, 75015, Paris, France. romain.levy@inserm.fr.
  • Béziat V; Université de Paris, Imagine Institute, 75015, Paris, France. romain.levy@inserm.fr.
  • Barbieux C; Pediatric Hematology-Immunology Unit, Necker Hospital for Sick Children, 75015, Paris, France. romain.levy@inserm.fr.
  • Puel A; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR 1163, 75015, Paris, France.
  • Bourrat E; Université de Paris, Imagine Institute, 75015, Paris, France.
  • Casanova JL; Université de Paris, Imagine Institute, 75015, Paris, France.
  • Hovnanian A; Laboratory of Genetic Skin Diseases, INSERM UMR 1163, 75015, Paris, France.
J Clin Immunol ; 40(2): 418-420, 2020 02.
Article en En | MEDLINE | ID: mdl-31993867

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antialérgicos / Dermatitis Atópica / Anticuerpos Monoclonales Humanizados / Síndrome de Job Límite: Female / Humans / Middle aged Idioma: En Revista: J Clin Immunol Año: 2020 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antialérgicos / Dermatitis Atópica / Anticuerpos Monoclonales Humanizados / Síndrome de Job Límite: Female / Humans / Middle aged Idioma: En Revista: J Clin Immunol Año: 2020 Tipo del documento: Article País de afiliación: Francia